Market Access & Health Technology Assessment
The PharmaBoardroom Market Access and Health Technology Assessment collection covers the processes by which pharmaceutical products are assessed for reimbursement, the criteria applied by national HTA bodies, and the managed entry agreement frameworks that govern access for innovative medicines across key markets.
Health technology assessment has become central to pharmaceutical market access globally. From NICE in the UK and G-BA in Germany to HAS in France and PBAC in Australia, each national body applies its own methodology and criteria, and understanding these in detail is essential for teams preparing submissions and negotiating reimbursement.
Each guide in this collection is developed with local experts who have direct experience of the HTA process in that market. Browse below to find the guide for your target market.
